View News Comments
 |
 |
Link Information - Click to View
Rate Story:
Total votes: 0
Bavarian Nordic vaccine helps prolong life in prostate cancer trial
An experimental therapeutic vaccine from Danish drugmaker Bavarian Nordic helped significantly extend survival in patients with advanced prostate cancer, according to results of a small early-stage trial conducted by the U.S. National Cancer Institute.
An experimental therapeutic vaccine from Danish drugmaker Bavarian Nordic helped significantly extend survival in patients with advanced prostate cancer, according to results of a small early-stage trial conducted by the U.S. National Cancer Institute.
Source: Reuters
Posted on: Wednesday, Feb 25, 2015, 5:56am
Views: 1165
Posted on: Wednesday, Feb 25, 2015, 5:56am
Views: 1165
 |
 |
Add Comment?
 |
 |
Friends